Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma
Clinical trial NCT00003079 · COMPLETED
Trial details
- NCT number
- NCT00003079
- Sponsor
- Virginia Commonwealth University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1997-09-01
- Primary completion
- 2001-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.